Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 11-20 of 550 total displayed.

Past content

Original Contributions
Lipid Profile Components and Risk of Ischemic Stroke: The Northern Manhattan Study (NOMAS)

Joshua Z. Willey; Qiang Xu; Bernadette Boden-Albala; Myunghee C. Paik; Yeseon Park Moon; Ralph L. Sacco; Mitchell S. V. Elkind
Arch Neurol 2009; 66: 1400-1406. [Abstract] [Full text] [PDF]  

Original Contributions
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

Christoph U. Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M. Kane; Anil K. Malhotra
JAMA 2009; 302: 1765-1773. [Abstract] [Full text] [PDF] [ eTables ]  

Editorials
Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents

Christopher K. Varley; Jon McClellan
JAMA 2009; 302: 1811-1812. [Extract] [Full text] [PDF]  

Original Investigations
Evaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels

Steven A. Grover; Mohammed Kaouache; Lawrence Joseph; Philip Barter; Jean Davignon
Arch Intern Med 2009; 169: 1775-1780. [Abstract] [Full text] [PDF]  

Editor's Correspondence
ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses—Reply

Jackson T. Wright Jr; Jeffrey L. Probstfield; William C. Cushman; Sara Pressel; Jeffrey A. Cutler; Barry R. Davis; Paula T. Einhorn; Mahboob Rahman; Paul K. Whelton; Charles E. Ford; L. Julian Haywood; Karen L. Margolis; Suzanne Oparil; Henry R. Black; Michael H. Alderman; for the ALLHAT Collaborative Research Group
Arch Intern Med 2009; 169: 1810-a-1811-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses

Macaulay A. C. Onuigbo
Arch Intern Med 2009; 169: 1810. [Extract] [Full text] [PDF]  

Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction—Reply

Pia R. Kamstrup; Børge G. Nordestgaard
JAMA 2009; 302: 1645-a-1646-a. [Extract] [Full text] [PDF]  

Letters
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction

Steven R. Jones; Roger S. Blumenthal
JAMA 2009; 302: 1645. [Extract] [Full text] [PDF]  

Research Letters
Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors

Devin M. Mann; Mark Woodward; Fen Ye; Marie Krousel-Wood; Paul Muntner
Arch Intern Med 2009; 169: 1718-1720. [Extract] [Full text] [PDF]  

Preliminary Communications
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

Marietta Charakida; Christian Besler; Joana R. Batuca; Shirish Sangle; Susanna Marques; Miguel Sousa; Guosu Wang; Dimitris Tousoulis; Jose Delgado Alves; Stavros P. Loukogeorgakis; Charles Mackworth-Young; David D’Cruz; Thomas Luscher; Ulf Landmesser; John E. Deanfield
JAMA 2009; 302: 1210-1217. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55